We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tanzania Outlines Devicemaker Obligations in Clinical Trials
Tanzania Outlines Devicemaker Obligations in Clinical Trials
January 5, 2012
The Tanzania Food and Drugs Authority (TFDA) requires formal reports for serious adverse events (SAE) and suspected unexpected serious adverse reactions (SUSAR) in clinical trials conducted in the country, according to a draft guideline for sponsors, investigators and contract review organizations.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor